Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension

Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension

In this 24-week study, spirapril antihypertensive effect and organo-protection was assessed inpatients with metabolic syndrome (MS) and arterial hypertension (AH). Parameters of 24-hour blood pressure (BP) monitoring (systolic and diastolic BP - 24 hours, daytime, nighttime) and pulse BP were signif...

Full description

Bibliographic Details
Main Authors: V. E. Oleynikov, A. S. Gerasimova, I. B. Matrosova, Yu. A. Tomashevskaya
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2007-08-01
Series:Российский кардиологический журнал
Subjects:
arterial hypertension
metabolic syndrome
insulin resistance
target organ damage
spirapril
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2184

Internet

https://russjcardiol.elpub.ru/jour/article/view/2184

Similar Items